Inagene Diagnostics Inc. and The Newly Institute partner to optimize treatment for Canadians living with pain and/or mental health conditions TORONTO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Canadian pharmacogenetic (PGx) testing provider, Inagene Diagnostics Inc., has partnered with The Newly Institute, an advanced network of medically...

Canadians living with mental health conditions stand to save over $57 billion with use of pharmacogenetic testing TORONTO, June 08, 2021 (GLOBE NEWSWIRE) -- Inagene Diagnostic Inc., a Canadian pharmacogenetic testing company, and Calian Group Ltd., one of Canada's largest national health services organizations,...